Webinar 1: Progression. Now What? Necessary Testing, Common Mechanisms of EGFR-Dependent Resistance, and Possible Treatment Strategies
Guests: Joshua Bauml, MD and Melina Marmarelis, MD, PhD; University of Pennsylvania, Philadelphia, PA
Education
Ask the Experts
Webinar series highlighting experts in the field of EGFR lung cancer. We'd like to thank Blueprint Medicine for sponsoring the webinar series on Progression and Resistance for the EGFR Resisters community. Also, thank you to CEC Oncology for your assistance with the coordination and production.
Webinar 2: I Have Another Oncogene Driver! What Are the Implications of This?
Guests: Zofia Piotrowska, MD and Catherine Meador, MD, PhD; Mass General, Boston
Webinar 3: What is Histological Transformation, and Can it Be Treated?
Guests: Helena Yu, MD and Joseph Chan, MD, PhD; Memorial Sloan Kettering Cancer Center, New York City
EGFR Resisters Welcome and Educational Video
An educational overview for EGFR+ patients and their caregivers and how we can help.
Who’s in? Who’s out? How Patients are Selected for Clinical Trials?
Dr. Nieva discusses patient selection for clinical trials and the Epidemiology of Young Lung Cancer trial that he is leading with GO2 Foundation/ALCMI.
Downloadable Fact Sheets
We'd like to thank Eli Lilly for supporting the development of these fact sheets and Breath of Hope Kentucky for partnering with us in their creation.
Your EGFR-positive lung cancer journey
What is EGFR-positive lung cancer and how will I know if I have it?
Treatment options for EGFR-positive lung cancer
What to expect after learning you have EGFR-positive lung cancer
